Skip to Main Content

Paper Details

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Res Sq
3
2022
Autoimmunity to, COVID-19, IFN, IFN-, IFN-?, IFRs, RRD, SARS-CoV, SARS-CoV-2, deceased, patients, type I IFN autoantibodies, type I IFNs
Author NameAffiliation
Hans-Heinrich HoffmannRockefeller University.
James R HeathInstitute for Systems Biology.
Robert L Nussbaum
Giorgio CasariVita-Salute San Raffaele University, and Clinical Genomics, IRCCS Ospedale San Raffaele
Luis F ReyesUniversidad de La Sabana
Christian ErikstrupAarhus University Hospital.
Jacques FellayEcole Polytechnique Federale de Lausanne.
Kaya BilguvarYale University School of Medicine.
Richard P LiftonThe Rockefeller University.
Richard P LiftonThe Rockefeller University.
Shrikant ManeYale University School of Medicine.
Mark S AndersonDiabetes Center, University of California San Francisco
Peter K GregersenFeinstein Institutes for Medical Research
Charles M RiceRockefeller University.
  • 1 - 14

Datasets

Release 1.2